• Explore /
  • Poster
  • / <span>Systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.</span>

Systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.

Abstract Poster

Authors

null

Nabila Nora Bennani

Division of Hematology, Mayo Clinic, Rochester, MN

Nabila Nora Bennani , Joselle Cook , Kah-Whye Peng , Susan Michelle Geyer , Brenda F. Ginos , Lianwen Zhang , Sharina C. Macapagal , Thomas E. Witzig , Javier Munoz , Stephen M Broski , Stephen J. Russell , Martha Lacy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Cell Therapy, Bispecific Antibodies, and Autologous Stem Cell Transplantation for NHL, HL, or CLL

Clinical Trial Registration Number

NCT03017820

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7530)

DOI

10.1200/JCO.2023.41.16_suppl.7530

Abstract #

7530

Poster Bd #

81

Abstract Disclosures

Similar Posters

First Author: Andrzej J. Jakubowiak

First Author: Sosana Delimpasi

First Author: Andrew Jenho Yee

First Author: David H. Vesole